News: Featured news

12 December 2022

Committed to Accelerating the Halal Industry, Dexa Group Achieved Indonesia Halal Industry Awards 2022

As a pioneer in the implementation of research for the Indonesia Indigenous Modern Medicine (OMAI) products certified by the Halal Product Assurance System, Dexa Group has achieved the Indonesia Halal Industry Award (IHYA) 2022 for the Best Halal Innovation category. The award held by the Ministry of Industry of the…
19 October 2022

President Jokowi Visits Dexa Group Booth at Trade Expo Indonesia 2022

The President of the Republic of Indonesia, Joko Widodo (Jokowi), visited the Dexa Group booth at the 2022 Trade Expo Indonesia (TEI) at ICE BSD City, Tangerang, Mr. Dexa Group Commissioner, Mrs. Gracianti Soetikno-Pandji, welcomed the President. The President was accompanied by the Coordinating Minister for the Economy of the…
25 December 2021

Dexa Group Wins Top CSR Program Award 2021 from West Java Provincial Government

Dexa Group through Dharma Dexa has been awarded Corporate Social Responsibility by the West Java Provincial Government in recognition of their contributions to the implementation of social and environmental responsibility programs in the West Java Area. The virtual ceremony was held by Regional Development Planning Agency/Bappeda of West Java Province…
17 December 2021

CEO Dexa Group Achieved Most Acclaimed CEO Award 2021

For the ability to adapt and continue to innovate to maintain the continuity of the company's business activities, CEO Dexa Group Mr. Ferry Soetikno received the "Indonesia Most Acclaimed CEO Award 2021" with Outstanding Leadership in Expanding Corporate Business Segmentation in the pharmaceutical category from WartaEkonomi.co.id. The Most Acclaimed CEO…
15 December 2021

Dexa Group Donates Medicines through BNPB for Semeru Eruption Victims

The national pharmaceutical company Dexa Group participated in donating a number of medicines through the National Disaster Management Agency (BNPB) to treat the health of residents affected by the eruption of Mount Semeru in Lumajang, East Java. According to BPNP data on December 6, 2021, residents affected by the eruption…
8 December 2021

Dexa Group Appreciated by Government for Contribution to Improving National Industry Competitiveness through OMAI Research and Innovation

Taking an active role in increasing the competitiveness of the national industry through research and sustainable technological innovation in the pharmaceutical sector, Dexa Laboratories of Biomolecular Sciences (DLBS) received the Rintisan Teknologi Industri 2021 award from the Ministry of Industry of the Republic of Indonesia. The award was handed over…
22 October 2021

Dexa Medica Wins Primaniyarta Award 2021 for OMAI Stimuno’s Marketing Achievements Abroad

PT Dexa Medica won the Primaniyarta 2021 award for the New Market Pioneer category. The Primaniyarta 2021 winners' awards were announced at the opening ceremony of the Trade Expo Indonesia Digital Edition (TEI DE), on Thursday, October 21, 2021. The President of the Republic of Indonesia, Mr. Joko Widodo (Jokowi)…
13 October 2021

HerbaASIMOR Wins Indonesia Digital Marketing Champion 2021 Award

Dexa Medica through HerbaASIMOR won the Indonesia Digital Marketing Champion 2021 award as the 1st Digital Marketing Champion 2021 in the Healthcare Products category with the title Very Good. This award was achieved for Dexa Medica's achievements in improving business performance through digital platforms. The award was given by SWA's…
1 September 2021

Dexa Group Ramps Up Business in SE Asia by Launching Glorious Dexa Singapore Pte. Ltd.

Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore…
23 August 2021

Government Appreciates Industry 4.0 Implementation by Dexa Group

The Ministry of Industry continues to improve the competitiveness of the national industry through the transformation towards industry 4.0. In this regard, as a leading international pharmaceutical company in Indonesia, Dexa Group has implemented Industry 4.0 in the production process to distribution. President Director of PT Ferron Par Pharmaceuticals, Mr.…